FINANCIALS

While the uncertainty of the COVID-19 pandemic continued into FY21, Ariadne Labs had a steady increase in grant funding and stable philanthropic fundraising. Our efficient stewardship of funds allowed us to end the year with stable expenses, and we head into FY22 with a positive financial outlook.

	FISCAL YEAR ’19	FY ’20	FY ’21
Revenue ($ Millions)	$19.2	$27.8	$27.0
Expenses ($ Millions)	$20.4	$25.7	$25.1